Microbot Medical Expands Global Reach as Israel Grants Marketing Approval for LIBERTY Endovascular Robotic System Microbot Medica a commercial-stage medical device company focused on advancing robotic technologies for endovascular procedures,…
Veradigm Files 2023 and 2024 Annual Reports, Marks Key Milestone in Financial Reporting Recovery Veradigm, a provider of healthcare technology, clinical solutions, and revenue cycle management services for independent physician…
Encompass Health Expands Rehabilitation Services with New 36-Bed Hospital in Bridgeport, West Virginia Encompass Health, a leading provider of inpatient rehabilitation services in the United States, has announced plans to…
Elevance Health Expands Digital Access to Healthcare, Helping Bridge the Digital Divide Across America As healthcare becomes increasingly dependent on digital technology, access to reliable internet, connected devices, and digital…
Health Net Named Among America’s Best Customer Service in Financial Services 2026 by USA TODAY Health Net, one of California’s most established Medi-Cal managed care health plans and a company…
GW, MFA and UHS Finalize Agreement to Transition Clinical Operations to Capital Medical Group The George Washington University (GW), Medical Faculty Associates, Inc. (MFA), and Universal Health Services, Inc. (UHS)…
Henry Schein Appoints William K. “Dan” Daniel as Independent Chairman Following Stanley Bergman’s Retirement Henry Schein,announced the appointment of William K. “Dan” Daniel as Independent Chairman of the Board, marking…
Fulgent Genetics Announces Full Abstract Publication of FID-007 Combination Therapy in Head and Neck Cancer at ASCO 2026 Fulgent Genetics, a technology-driven life sciences company with established laboratory services and…
Datroway® Receives U.S. FDA Approval as First TROP2-Directed Antibody Drug Conjugate for First-Line Treatment of Metastatic Triple-Negative Breast Cancer in Patients Not Eligible for PD-1/PD-L1 Inhibitor Therapy Daiichi Sankyo and…
FDA Approves Gilead’s Hepcludex, Marking a Breakthrough for Patients Living With Chronic Hepatitis Delta The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hepcludex® (bulevirtide-gmod) 8.5 mg,…
Johnson & Johnson and Abu Dhabi Launch Global Surgical Intelligence Network to Advance AI-Powered Operating Rooms Johnson & Johnson has announced a landmark collaboration with the Department of Health –…
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Guardant Health a leading precision oncology company headquartered in Palo Alto, California, has announced the approval and issuance of a…